Phospholipid Fraction From Bovine Lung (Surfactant) Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 50 mg
Reference Brands:
Category: Respiratory Disorder
Injection is a natural surfactant that is extracted from bovine lungs. It is a sterile, non-pyrogenic, bovine lung extract composed of phospholipids, neutral lipids, fatty acids and surfactant associated proteins. Injection is primarily indicated for babies and premature infants with body weight of 1250g and below. PHOSPHOLIPID FRACTION FROM BOVINE LUNG (SURFACTANT) is available in Injection and strengths such as 50 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, PHOSPHOLIPID FRACTION FROM BOVINE LUNG (SURFACTANT) is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
| Technical Specifications & Supply Details | |
|---|---|
| Lead Time | 7 to 60 days (depending on batch size & schedule) |
| MOQ | As per manufacturer’s batch size |
| COA | Available with every batch |
| Regulatory Dossier / DMF | Available upon request |
| Export Documentation | FSC, COA, Manufacturing License, Product Permission |
| Standards | IP, BP, USP |
| Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
PHOSPHOLIPID FRACTION FROM BOVINE LUNG (SURFACTANT) can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
Product Description: It is used to treat severe breathing difficulties in babies which may be caused due to a condition called respiratory distress syndrome. Premature babies, in particular, are at a huge risk of developing respiratory distress syndrome due to inadequate production of a substance called surfactant by the lungs.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Related Products
Ensifentrine
Strength:
3 mg per 2.5 mL
Form: Inhalation solution
Reference Brands: Ohtuvayre (USA)
View DetailsMepolizumab
Strength:
100 mg/1 mL
Form: injection (prefilled syringe)
Reference Brands: Nucala (USA/EU)
View DetailsLevalbuterol
Strength:
0.31 mg, 0.63 mg, 1.25 mg
Form: Inhalation solution
Reference Brands: Xopenex (USA/EU)
View DetailsQuick Response Guaranteed | Verified Suppliers